RESUMO
BACKGROUND: Ankle Foot Orthoses (AFOs) are frequently prescribed to manage gait impairments in children with physical disability, and it is important that AFOs are prescribed and fitted appropriately to maximize potential benefits. AFO tuning, manipulation of the AFO footwear combination (AFO-FC) by means of video vector analysis, is routinely used to optimize AFO use. However, the incidence or types of changes that are implemented after this type of orthotic review are unknown. RESEARCH QUESTION: To investigate the impact of a multi-disciplinary video vector clinic on AFO provision in children with physical disability. METHODS: All children who attended a video vector clinic over a period of 10-years from the establishment of the clinic were included in the study. Outcomes of the clinic were grouped into 5 categories: (1) No change to AFO-FC; (2) Altered/tuned AFO-FC; (3) Discontinued AFO-FC; (4) Recast AFO; (5) Change in prescription. Data were summarised narratively. RESULTS: 141 independently ambulant children were included. The diagnoses were bilateral cerebral palsy (39â¯%, n=55), unilateral cerebral palsy (38â¯%, n=54), spina bifida (9â¯%, n=13), hereditary spastic paraparesis (2â¯%, n=3) and other (11â¯%, n=16). No changes were made in 52â¯% of cases (n=74), tuning in 22â¯% of cases (n=31), the AFO was recast in 13â¯% of cases (n=19) and discontinued in 10â¯% of cases (n=14). A prescription change was recommended in 3â¯% of cases (n=4). SIGNIFICANCE: Our findings suggest that the video vector clinic is a time efficient and effective means of assessing gait function in children with AFOs. Without assessment at the clinic, most of the children assessed would likely have been referred for a full and more time consuming 3-dimensional gait analysis. Video vector analysis at the initial AFO fitting may improve alignment and possibly reduce non-compliance at an earlier stage.
RESUMO
By 2050 more than 1.6 billion women worldwide will be of post-reproductive age, with >75% reporting severe menopausal symptoms. The last few years saw a gradual uplift in public awareness reaffirming the health needs of women with menopause. Still, effective translation of available evidence on menopause treatments is hindered by several methodological limitations and poor research conduct. We argue that a paradigm shift is required in menopause research to address the remaining knowledge gap and guide safe evidence-based care provision. A critical misconception across studies on menopause is the assumption that women represent a homogeneous group who respond similarly to a particular therapy irrespective of their exposure and individual risk factors. We highlight potential solutions to optimize the quality of future research in menopause including adopting robust trial methodology, standardize outcome reporting to capture quality-of-life measures, and improve lay patient and public involvement in future research.
Assuntos
Menopausa , Qualidade de Vida , Feminino , Humanos , ReproduçãoRESUMO
An endogenous adrenocorticotropic hormone (ACTH) concentration above the reference interval (RI) is commonly used as means for diagnosing equine pituitary pars intermedia dysfunction (PPID). Basal ACTH concentrations are highly dependent on photoperiod and RIs should be month- and location-specific. To date, no ACTH RIs have been specifically established for South Africa. This study aimed to determine geographically and seasonally relevant RIs for equine ACTH in the Gauteng province of South Africa. A longitudinal prospective study was conducted over twelve months to determine ACTH RIs for a representative population of healthy South African horses in the Gauteng province. Eighty clinically healthy horses under 12 years of age were recruited for monthly venous blood sample collection, from July 2019 to June 2020. ACTH was measured using a chemiluminescent assay. RIs were constructed for each month of the year. This South African population showed similar temporal changes in ACTH concentrations to those previously observed in other locations. Upper reference limits were at their lowest in early summer (21.4 pg/ml, 90% CI 20.8-21.7) with a pronounced increase in autumn (60.6 pg/ml, 90% CI 53.1-62.7), and tapered off in winter (22.3 pg/ml, 90% CI 19.9-23.2). The month-specific ACTH RIs generated in this study will improve the accuracy of diagnosis and monitoring of PPID in the local equine population. These results highlighted the previously recommended need for seasonal and location-specific RIs.
Assuntos
Doenças dos Cavalos , Doenças da Hipófise , Cavalos , Animais , Hormônio Adrenocorticotrópico , África do Sul , Estudos Prospectivos , Doenças dos Cavalos/diagnóstico , Doenças da Hipófise/diagnóstico , Doenças da Hipófise/veterináriaRESUMO
SETTING: Adverse social determinants of health for people who are foreign-born are key drivers of TB-related disparity, particularly in low-incidence countries. Patients diagnosed with infectious TB and their family members must confront psychosocial challenges which may deepen pre-existing health inequities. However, little is known about patient and family members' perspective on these experiences. OBJECTIVE: To explore the infectious TB experience of patients and family members who are foreign-born. DESIGN: This study formed one component of an ecologically framed, qualitative case study conducted in Calgary, AB, Canada. Data were collected using semi-structured interviews, chart review and field notes, and analysed thematically. RESULTS: Eight families were represented in the sample comprised of six patients and 13 family members. Many patients and family members experienced high levels of fear and stress for months following the patient's diagnosis. Isolation was pervasive and multifaceted for both patients and family members. Intra-family support was critical for managing during early stages when the situation was most challenging. Support from outside the family was not prominent and attempts to obtain support from government programmes for paid sick leave and health insurance were mostly unsuccessful. CONCLUSION: Patients and family members who are foreign-born experience multidimensional isolation as a result of TB stigma, language barriers and poor access to government programmes. TB programmes cannot meet family needs alone and systems of support should be created through collaboration with government institutions, and organisations serving ethnocultural communities.
CONTEXTE: Les déterminants sociaux défavorables en matière de santé pour les personnes nées à l'étranger sont des facteurs clés d'inégalités face à la TB, notamment dans les pays à faible incidence. Les patients atteints de TB contagieuse et leurs proches sont confrontés à des difficultés psychosociales, qui peuvent creuser les inégalités préexistantes en matière de santé. Cependant, le ressenti des patients et de leurs proches concernant cette expérience est peu connu. OBJECTIF: Analyser l'expérience des patients, nés à l'étranger, atteints de TB contagieuse et de leurs proches. MÉTHODES: Cette étude est l'une des composantes d'une étude de cas qualitative et écologique réalisée à Calgary, AB, Canada. Les données ont été recueillies à l'aide d'entretiens semi-structurés, d'analyses des dossiers et de notes de terrain ; elles ont ensuite été analysées thématiquement. RÉSULTATS: Huit familles étaient représentées dans l'échantillon, composé de six patients et de 13 proches. De nombreux patients et proches ont décrit d'intenses niveaux de stress et de peur au cours des mois ayant suivi le diagnostic des patients. Les patients et leurs proches ont subi un isolement systématique aux multiples facettes. Au stade précoce de la maladie, lorsque la situation était la plus compliquée, l'aide intra-familiale s'est avérée essentielle pour la prise en charge des patients. Les familles n'ont reçu que peu d'aide en dehors du cadre familial et les tentatives effectuées pour obtenir l'aide des programmes gouvernementaux (rémunération du congé maladie et assurance maladie) se sont avérées infructueuses la plupart du temps. CONCLUSION: Les patients et leurs proches, nés à l'étranger, ont subi un isolement pluridimensionnel en raison de la stigmatisation liée à la TB, de la barrière de la langue et du manque d'accès aux programmes gouvernementaux. Les programmes de lutte contre la TB ne peuvent pas satisfaire les besoins des familles à eux seuls. Des systèmes d'aide devraient être créés au travers de collaborations avec les institutions gouvernementales et les organisations Åuvrant auprès des communautés ethnoculturelles.
RESUMO
BACKGROUND: Non-classic lobular carcinoma in situ (NC-LCIS) represents a spectrum of lesions, histologically distinct from classic LCIS (C-LCIS) and ductal carcinoma in situ (DCIS). Several studies have reported on the safety of breast conservation (BCS) in patients with DCIS or invasive breast cancer and concomitant C-LCIS, yet there are no data addressing this question for patients with concomitant NC-LCIS. We evaluated local recurrence (LR) after BCS in patients with DCIS or invasive cancer and concomitant NC-LCIS. PATIENTS AND METHODS: We searched institutional databases using natural language processing to identify patients with DCIS or invasive breast cancer and concomitant NC-LCIS treated with BCS between 2000 and 2015. Charts were reviewed to collect demographics, disease and treatment details, and recurrence events. All results represent descriptive analyses. RESULTS: We identified 71 patients with DCIS (n = 13) or invasive cancer (n = 58) and concomitant NC-LCIS treated with BCS. Median patient age was 59 years (33-77 years), and median invasive tumor size was 1.2 cm (0.1-6.9 cm); 62% of DCIS and 79% of invasive cancer patients had hormone receptor (HR)-positive disease. Among DCIS patients, seven (54%) received radiation and none hormonal therapy. Among those with invasive cancer, 52 (90%) received radiation, 17 (29%) received chemotherapy and 44 of 55 with HR-positive disease (78%) received hormonal therapy. At median follow-up of 79 months (1-265 months), the LR rate was 8% and 2% among patients with DCIS and invasive cancer, respectively. CONCLUSION: NC-LCIS is rarely present in association with DCIS or invasive cancer, and it does not appear to impact LR outcomes following BCS.
Assuntos
Carcinoma de Mama in situ , Neoplasias da Mama , Carcinoma in Situ , Carcinoma Intraductal não Infiltrante , Carcinoma Lobular , Carcinoma de Mama in situ/patologia , Carcinoma de Mama in situ/cirurgia , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Carcinoma in Situ/patologia , Carcinoma Intraductal não Infiltrante/patologia , Carcinoma Intraductal não Infiltrante/cirurgia , Carcinoma Lobular/patologia , Carcinoma Lobular/cirurgia , Contraindicações , Feminino , Hormônios , Humanos , Pessoa de Meia-IdadeRESUMO
Glutamate and N-acetylaspartate have been investigated in the neuropathology of chronic schizophrenia, with fewer studies focusing on early phase psychosis. Additionally, there has been little review and synthesis of the literature focused on multiple brain regions. This systematic review aims to provide a clear report of the current state of research on glutamate and n-acetylaspartate concentrations in early phase psychosis (defined as the first five years following psychosis onset) in multiple brain regions. Existing literature was searched systematically to compile reports of glutamate/glutamate+glutamine (Glx) and n-acetylaspartate absolute levels and ratios in both male and female individuals with early phase psychosis. Reports on glutamate/Glx concentrations in the medial prefrontal region and thalamus were varied, but the majority of reports suggested no alterations in EPP. No studies reported glutamate alterations in the hippocampus or cerebellum. There was no evidence for n-acetylaspartate alterations in the caudate, basal ganglia, and medial prefrontal cortex, and minimal evidence for NAA reductions in the thalamus, anterior cingulate cortex, and hippocampus. Future research should focus on the regions that are less commonly reported, and should aim to explore possible confounds, such as medication status and substance use.
Assuntos
Ácido Glutâmico , Transtornos Psicóticos , Ácido Aspártico/análogos & derivados , Feminino , Glutamina , Humanos , Masculino , Espectroscopia de Prótons por Ressonância Magnética , Transtornos Psicóticos/diagnóstico por imagemRESUMO
BACKGROUND: Refugees are at increased risk of developing tuberculosis (TB) soon after resettlement. Targeting high-risk populations for latent tuberculosis infection (LTBI) screening and treatment is an important measure towards eliminating TB in low incidence countries, however, there are low rates of screening and treatment completion in the LTBI cascade of care. The authors hypothesized that an interferon-gamma release assay (IGRA) screening strategy would lead to a higher proportion of refugees completing LTBI screening and treatment, compared to sequential screening with tuberculin skin test (TST) and confirmatory IGRA. METHODS: This retrospective cohort study included eligible refugees screened with a sequential strategy versus a solo-IGRA strategy at different time periods from a centralized refugee clinic. The primary outcome was the proportion completing LTBI screening in each cohort. RESULTS: A total of 471 subjects were included (240 in sequential screening, 231 in solo-IGRA screening). 54% of refugees completed LTBI screening with sequential testing, compared to 85% of those screened with a solo-IGRA. Time to completing screening was also shorter in the solo-QFT group (difference 16.5 days, p < 0.01, 95% confidence interval 9.3, 23.7). There was a higher incidence of LTBI diagnosis in the solo-IGRA group (41 versus 20, p = 0.002). Screening completion was predicted by solo-IGRA screening (aOR 3.74, 95% confidence interval 2.30, 6.09; p < 0.001) and if refugees were privately-sponsored (aOR 2.81, 95% confidence interval 1.53, 5.15; p = 0.001). Treatment completion rates did not differ between groups. CONCLUSION: This study has identified fewer dropouts in the LTBI cascade of care if a solo-IGRA strategy is used for screening. An IGRA should be strongly considered as the screening method for refugees arriving in low-incidence settings if resources are available.
Assuntos
Testes de Liberação de Interferon-gama , Tuberculose Latente , Humanos , Tuberculose Latente/diagnóstico , Tuberculose Latente/epidemiologia , Programas de Rastreamento , Estudos Retrospectivos , Teste TuberculínicoRESUMO
SETTING: Identification, assessment, and treatment of latent TB infection (LTBI), collectively known as the LTBI cascade of care, is critical for TB prevention. OBJECTIVE: The objective of this research, conducted within the ACT4 trial, was to assess and strengthen the LTBI cascade of care for household contacts at Calgary TB Services, a clinic serving a predominately foreign-born population in Western Canada. DESIGN: Baseline assessment consisted of a retrospective LTBI cascade analysis of 32 contact investigations, and questionnaires administered to patients and health care workers. Four solutions were implemented in response to identified gaps. Solution impact was measured for 6 months using descriptive statistics. RESULTS: Pre-implementation, 56% of household contacts initiated treatment. Most contacts were lost to care because the tuberculin skin test (TST) was not initiated, or physicians did not recommend treatment. Evening clinics, a patient education pamphlet, a nursing workshop, and treatment recommendation guidelines were implemented. Post-implementation, losses due to LTBI treatment non-recommendation were reduced; however, the overall proportion of household contacts initiating treatment did not increase. CONCLUSION: Close engagement between researchers and TB programmes can reduce losses in the LTBI cascade. To see sustained improvement in overall outcomes, long-term engagement and data collection for ongoing problem-solving are required.
CONTEXTE: L'identification, l'évaluation et le traitement de l'infection tuberculeuse latente (LTBI) collectivement connus sous le nom de « cascade de soins de la LTBI ¼ sont essentiels à la prévention de la TB. OBJECTIF: L'objectif de cette étude, réalisée dans le cadre de l'essai ACT4, était d'évaluer et de renforcer la cascade de soins de la LTBI pour les contacts domestiques au Calgary TB Services, une clinique traitant principalement une population née à l'étranger dans l'ouest du Canada. PLAN: Il s'agissait d'une évaluation initiale comprenant une analyse rétrospective de la cascade de soins de la LTBI de 32 recherches de contacts et des questionnaires administrés aux patients et aux professionnels de santé. Quatre solutions ont été mises en place en réponse aux lacunes identifiées. L'impact des solutions a été mesuré pendant 6 mois à l'aide de statistiques descriptives. RÉSULTATS: Avant la mise en place des solutions, 56% des contacts domestiques avaient démarré un traitement. La plupart des contacts ont été perdus de vue car l'intradermoréaction à la tuberculine (TST) n'avait pas été effectuée ou car les médecins ne recommandaient pas de traitement. Des solutions ont été mises en place, telles que l'ouverture des cliniques en soirée, un dépliant informatif pour les patients, un atelier de travail à destination des infirmiers et des directives thérapeutiques. Après la mise en place des solutions, les pertes dues à l'absence de recommandation de traitement contre la LTBI ont été réduites, mais la proportion globale de contacts domestiques démarrant un traitement n'a pas augmenté. CONCLUSION: Une collaboration étroite entre chercheurs et programmes de lutte contre la TB peut réduire les pertes observées au cours de la cascade de soins de la LTBI. Afin d'obtenir une amélioration durable des résultats globaux, un engagement de long terme et un recueil des données sont requis pour résoudre les problèmes actuels.
RESUMO
To determine the variation in practices on meticillin-resistant Staphylococcus aureus (MRSA) surveillance and management of MRSA-colonized patients amongst 17 acute healthcare facilities in Singapore, the Ministry of Health convened a sharing session with Infection Prevention and Control Leads. All hospitals practised close to universal MRSA entry swabbing in keeping with national policy. There were, however, major variations in the response to both positive and negative surveillance swabs across facilities including the role of routine antiseptic bathing and MRSA decolonization. Most undertaking decolonization considered its role to be in 'bioburden reduction' rather than longer-term clearance.
Assuntos
Anti-Infecciosos Locais , Infecção Hospitalar , Staphylococcus aureus Resistente à Meticilina , Infecções Estafilocócicas , Banhos , Portador Sadio/prevenção & controle , Infecção Hospitalar/prevenção & controle , Hospitais , Humanos , Controle de Infecções , Singapura , Infecções Estafilocócicas/prevenção & controleAssuntos
COVID-19/terapia , Disgeusia/terapia , Transtornos do Olfato/terapia , SARS-CoV-2/isolamento & purificação , Idoso , COVID-19/diagnóstico , Disgeusia/virologia , Feminino , Humanos , Imunização Passiva , Transtornos do Olfato/virologia , Pandemias , Reação em Cadeia da Polimerase Via Transcriptase Reversa , SARS-CoV-2/genética , Olfato , Paladar , Resultado do Tratamento , Soroterapia para COVID-19RESUMO
PURPOSE: From September 2010 until November 2019, Ireland's infant vitamin D supplementation policy recommended administration of 5 µg/day of vitamin D3 from birth to 12 months to all infants, regardless of feeding method. This study aims to examine policy adherence. METHODS: In the prospective COMBINE birth cohort study (recruited 2015-2017), detailed longitudinal supplement data were examined in 364 infants across the first year of life, according to product type, dose, frequency, and duration. Vitamin D supplement use at 2, 6, and 12 months in COMBINE was compared with the BASELINE cohort (recruited 2008-2011, n = 1949). RESULTS: In COMBINE, 92% of infants initiated supplementation at birth. The median supplementation duration was 51 (40, 52) weeks, with a range of 3-52 weeks. While supplementing, most parents (92%) used an exclusive vitamin D supplement as recommended and 88% gave 5 µg/day. Half (51%) gave vitamin D daily and a further 33% supplemented at least 3-6 times/week. Overall, 30% adhered fully to the policy, providing 5 µg vitamin D3 daily from birth to 12 months. A further 16% were broadly compliant, giving 5 µg frequently for the full 12 months. Vitamin D supplement use at 2, 6, and 12 months in COMBINE was 93%, 89%, and 72%, considerably higher than our earlier BASELINE cohort at 49%, 64%, and 44% at the same time points (all P < 0.001). CONCLUSIONS: We report a high level of vitamin D supplementation initiation at birth, with full to broad policy adherence among more than half of infants. There is scope to improve overall compliance by focusing on supplementation frequency.
Assuntos
Deficiência de Vitamina D , Vitamina D , Estudos de Coortes , Suplementos Nutricionais , Humanos , Lactente , Recém-Nascido , Irlanda , Políticas , Estudos Prospectivos , Deficiência de Vitamina D/tratamento farmacológico , Deficiência de Vitamina D/epidemiologia , Deficiência de Vitamina D/prevenção & controleRESUMO
BACKGROUND: Preprint manuscripts, rapid publications and opinion pieces have been essential in permitting the lay press and public health authorities to preview data relating to coronavirus disease 2019 (COVID-19), including the range of clinical manifestations and the basic epidemiology early on in the pandemic. However, the rapid dissemination of information has highlighted some issues with communication of scientific results and opinions in this time of heightened sensitivity and global concern. MAIN TEXT: Rapid publication of COVID-19 literature through expedited review, preprint publications and opinion pieces are important resources for the medical scientific community. Yet the risks of unverified information loom large in times when the healthcare community is desperate for information. Information that has not been properly vetted, or opinion pieces without solid evidence, may be used to influence public health policy decisions. We discuss three examples of unverified information and the consequences in this time of high anxiety surrounding COVID-19. CONCLUSIONS: In an era when information can be widely and swiftly disseminated, it is important to ensure that the scientific community is not an inadvertent source of misinformation. This will require a multimodal approach, with buy-in from editors, publishers, preprint servers, authors and journalists. The landscape of medical publications has changed, and a collaborative approach is required to maintain a high standard of scientific communications.
Assuntos
Infecções por Coronavirus , Confiabilidade dos Dados , Pandemias , Pneumonia Viral , Registros Públicos de Dados de Cuidados de Saúde , Editoração , Betacoronavirus , COVID-19 , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/psicologia , Humanos , Disseminação de Informação , Pneumonia Viral/epidemiologia , Pneumonia Viral/psicologia , Saúde Pública , SARS-CoV-2 , Fatores de TempoAssuntos
Betacoronavirus , Infecções por Coronavirus , COVID-19 , Humanos , Pandemias , Pneumonia Viral , SARS-CoV-2 , SingapuraRESUMO
BACKGROUND: Previous studies have demonstrated improved outcomes at high-volume colorectal surgery centers; however, the benefit for patients who live far from such centers has not been assessed relative to local, low-volume facilities. METHODS: The 2010-2015 National Cancer Database (NCDB) was queried for patients with stage I-III colon adenocarcinoma undergoing treatment at a single center. A 'local, low-volume' cohort was constructed of 12,768 patients in the bottom quartile of travel distance at the bottom quartile of institution surgical volume and a 'travel, high-volume' cohort of 11,349 patients in the top quartile of travel distance at the top quartile of institution surgical volume. RESULTS: In unadjusted analysis, patients in the travel cohort had improved rates of positive resection margins (3.7% vs. 5.5%, p < 0.001), adequate lymph-node harvests (92% vs. 83.6%, p < 0.001), and 30- (2.2% vs. 3.9%, p < 0.001) and 90-day mortality (3.7% vs. 6.4%, p < 0.001). On multivariable logistic regression analysis adjusting for patient demographic, tumor, and facility characteristics, the cohorts demonstrated equivalent overall survival (HR: 0.972, p = 0.39), with improved secondary outcomes in the 'travel' cohort of adequate lymph-node harvesting (OR: 0.57, p < 0.001), and 30- (OR 0.79, p = 0.019) and 90-day mortality (OR 0.80, p = 0.004). CONCLUSIONS: For patients with stage I-III colon cancer, traveling to high-volume institutions compared to local, low-volume centers does not convey an overall survival benefit. However, given advantages including 30- and 90-day mortality and adequate lymph-node harvest, nuanced patient recommendations should consider both these differences and the unquantified benefits to local care, including cost, travel time, and support systems.
Assuntos
Neoplasias do Colo , Hospitais com Alto Volume de Atendimentos , Neoplasias do Colo/cirurgia , Hospitais com Baixo Volume de Atendimentos , Humanos , Estadiamento de Neoplasias , Estudos Retrospectivos , Taxa de Sobrevida , Viagem , Resultado do TratamentoRESUMO
BACKGROUND: The End TB Strategy calls for global scale-up of preventive treatment for latent tuberculosis infection (LTBI), but little information is available about the associated human resource requirements. Our study aimed to quantify the healthcare worker (HCW) time needed to perform the tasks associated with each step along the LTBI cascade of care for household contacts of TB patients. METHODS: We conducted a time and motion (TAM) study between January 2018 and March 2019, in which consenting HCWs were observed throughout a typical workday. The precise time spent was recorded in pre-specified categories of work activities for each step along the cascade. A linear mixed model was fit to estimate the time at each step. RESULTS: A total of 173 HCWs in Benin, Canada, Ghana, Indonesia, and Vietnam participated. The greatest amount of time was spent for the medical evaluation (median: 11 min; IQR: 6-16), while the least time was spent on reading a tuberculin skin test (TST) (median: 4 min; IQR: 2-9). The greatest variability was seen in the time spent for each medical evaluation, while TST placement and reading showed the least variability. The total time required to complete all steps along the LTBI cascade, from identification of household contacts (HHC) through to treatment initiation ranged from 1.8 h per index TB patient in Vietnam to 5.2 h in Ghana. CONCLUSIONS: Our findings suggest that the time requirements are very modest to perform each step in the latent TB cascade of care, but to achieve full identification and management of all household contacts will require additional human resources in many settings.
Assuntos
Administração de Caso , Pessoal de Saúde , Recursos em Saúde , Tuberculose Latente , Adulto , Benin , Canadá , Feminino , Gana , Humanos , Indonésia , Tuberculose Latente/diagnóstico , Tuberculose Latente/terapia , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Estudos de Tempo e Movimento , VietnãRESUMO
To determine the effectiveness of our messaging for hand hygiene compliance by profession, we conducted a hospital-wide survey followed by profession-specific focus group discussions to investigate impact, perceptions and areas for improvement. Results showed a good understanding that hand hygiene is a crucial part of the infection-prevention programme; however, the acceptance and impact of messages varied between professions and required tailoring. Motivation, use of influential role models and social cohesion should be considered when designing profession-specific messages to improve infection-prevention-related change uptake among healthcare professional groups.